BRIEF-Oxigene says Phase 2 study of CA4P met primary endpoint of improvement By: Reuters: Company News May 24, 2016 at 06:47 AM EDT * Oxigene announces results of Phase 2 study of CA4P in recurrent ovarian cancer published in journal of clinical oncology Read More >>